Galderma's global center of excellence for Aesthetics is in Uppsala

Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ–the skin–meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story.

"Galderma is currently investing over 2 billion SEK in a new manu facturing facility in Uppsala, where we today have over 500 employees working on development and manufacturing of Injectable Aesthetics products for the global market." - Kim Sandell, Head of Site Operations, Galderma

For more information: www.galderma.com

Employees: 6000 globally of which
500 in Sweden
Founded: 1981
Principal owners: EQT, ADIA
Product Brands Includes: for ex Cetaphil® and Restylane® portfolio